GlaxoSmithKline honors healthcare nonprofits with $40,000 IMPACT Award

RESEARCH TRIANGLE PARK, N.C., Nov. 8, 2012 /PRNewswire/ -- GlaxoSmithKline (GSK) today announced the five recipients of its annual GlaxoSmithKline IMPACT Awards. In total, the North Carolina and Philadelphia-area healthcare nonprofit organizations will receive $200,000 in grant funding ($40,000 each) for providing access to healthcare for the underserved in their communities.

(Photo: http://photos.prnewswire.com/prnh/20121108/PH08967 )

"The GlaxoSmithKline IMPACT Award winners are helping to make their communities stronger and healthier," said Mary Linda Andrews, Director of Community Partnerships, GSK. "The dedicated teams of professionals and volunteers at these organizations are working in innovative ways to provide access to healthcare at a time when people need it most."

The following organizations will receive their awards at a ceremony on December 11 in Research Triangle Park:

• Piedmont Health Services and Sickle Cell Agency, Greensboro, N.C.
• Restoration Place Ministries, Inc., Greensboro, N.C.
• The Servant Center, Inc., Greensboro, N.C.
• Triad Health Project, Greensboro, N.C.
• Institute for Safe Families, Philadelphia, Pa.

In North Carolina, GSK works in partnership with Durham-based Triangle Community Foundation (TCF), a grant making organization that connects resources with needs through community-based philanthropy.

"Millions of Americans fall between the gaps and are not receiving the most basic healthcare services," said Lori O'Keefe, COO at TCF. "Our partnership with GSK celebrates and supports groups that are filling those gaps and creating hope for thousands of members of our communities."

About the GlaxoSmithKline IMPACT Awards
The GlaxoSmithKline IMPACT Awards (whose name represents Innovation, Management, Partnership, Achievement, Community focus and Targeting needs of diverse and underserved populations) honor nonprofit organizations that have a significant impact on their communities and are capable, proactive and effective in their work.

To qualify for a GlaxoSmithKline IMPACT award, organizations must be located in the eligible counties and have a primary mission to provide access to community healthcare services. Each applicant must have annual total operating expenses between $160,000 and $3 million, and have been in existence as a 501(c)(3) nonprofit organization for at least five years.

All organizations are recognized for the success and achievements of their existing overall body of work, not just for new or specific initiatives. A panel of healthcare delivery experts and GlaxoSmithKline representatives determine the winners based on a strong demonstration of ongoing success in providing access to healthcare, commitment to serving people in need, facilitation of healthcare delivery, creative partnerships and policy development, and a solid record of achievement, management and leadership. 

For more information regarding GSK's work with communities, please visit http://us.gsk.com/html/community/index.html.

About GlaxoSmithKline
GlaxoSmithKline – one of the world's leading research-based pharmaceutical and healthcare companies – is committed to improving the quality of human life by enabling people to do more, feel better and live longer.  For further information go to us.gsk.com, follow us on twitter.com/GSKUS or visit our blog (www.morethanmedicine.us.gsk.com/blog/).

About Triangle Community Foundation
Triangle Community Foundation is a nonprofit charity that manages $145 million in funds established by families, businesses, individuals, and organizations. From these funds, it makes grants to nonprofit organizations and administers a variety of programs for the community's benefit. The Foundation currently manages over 750 funds, ranging in size from $10,000 to $7 million, primarily for the benefit of Wake, Durham, Orange and Chatham counties. During the 2011-12 fiscal year, the Foundation granted more than $13 million to nonprofits, schools and community efforts. For more information, please visit www.trianglecf.org.

SOURCE GlaxoSmithKline